# Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma

> **NCT04661943** · PHASE2 · COMPLETED · sponsor: **Ou Bai, MD/PHD** · enrollment: 30 (actual)

## Conditions studied

- Diffuse Large B-cell Lymphoma

## Interventions

- **DRUG:** Tucidinostat

## Key facts

- **NCT ID:** NCT04661943
- **Lead sponsor:** Ou Bai, MD/PHD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04661943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04661943, "Maintenance Therapy of Chidamide in Patients With HBV Positive Diffuse Large B-cell Lymphoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04661943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*